Quick summary: Archived - Notice to Hospitals - Increased mortality and risk of serious adverse events when prophylactic heparin is abruptly discontinued in patients to be started on Xigris [drotrecogin alfa (activated)] for severe sepsis .
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Quick summary: Archived - Notice to Hospitals - Increased mortality and risk of serious adverse events when prophylactic heparin is abruptly discontinued in patients to be started on Xigris [drotrecogin alfa (activated)] for severe sepsis .
Detailed identifiers are not available here. Review the official notice before deciding whether your product is affected.
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
Answers based on the official recall notice.
Official product images from Health Canada.
Starting...
Similar recalls and safety notices.